NQO2 (NAD(P)H:quinone oxidoreductase 2), also known as QR2, is a cytosolic flavoprotein that catalyzes the reduction of quinones and related compounds. Unlike its well-studied relative NQO1 (NQO1), NQO2 uses dihydronicotinamide riboside (NRH) as its primary reducing cofactor rather than NAD(P)H. This enzyme has drawn attention for its roles in oxidative stress protection, xenobiotic metabolism, and more recently, in neurodegenerative diseases.
¶ Gene and Expression
The human NQO2 gene is located on chromosome 6p25.2 and encodes a protein of 231 amino acids. Expression patterns include:
- Brain: Neurons, astrocytes, particularly in basal ganglia
- Liver: Hepatocytes for xenobiotic metabolism
- Kidney: Renal tubular cells
- Heart: Cardiomyocytes
- Skeletal muscle: Muscle fibers
NQO2 is a flavoprotein with distinctive features:
- Flavin mononucleotide (FMN): Covalently bound prosthetic group
- Dimer formation: Functional homodimer
- Active site: Substrate binding pocket
- NAD(P)H-binding region: Different from NQO1
- Quinone binding site: Hydrophobic pocket
NQO2 catalyzes multiple reactions:
- Quinone reduction: Two-electron reduction to hydroquinones
- Nitro reduction: Reduction of nitroaromatics
- DT-diaphorase activity: Similar to NQO1 but different cofactor
- Oxidative stress protection: Prevents semiquinone formation
- Xenobiotic metabolism: Processes dietary and environmental compounds
- Antioxidant defense: Scavenges quinones
- Apoptosis regulation: Modulates p53 stability
- Coenzyme Q metabolism: Regenerates antioxidant forms
- Vitamin K metabolism: Reduces vitamin K3
- Iron metabolism: May affect ferritin regulation
NQO2 is implicated in AD:
- Oxidative stress: Altered in AD brains
- Amyloid interaction: May reduce quinone-amyloid reactions
- Mitochondrial function: Protects against oxidative damage
- Therapeutic potential: NQO2 activators under investigation
- Genetic associations: NQO2 variants in AD risk
In PD:
- Dopamine oxidation: NQO2 may process quinone metabolites
- Mitochondrial protection: Against oxidative stress
- Neuroinflammation: Modulates microglial responses
- Levodopa metabolism: May affect quinone formation
- Cancer: Altered expression in tumors
- Cardiovascular disease: Protective in atherosclerosis
- Aging: Declines with age
NQO1 and NQO2 have overlapping but distinct functions:
- Different cofactors: NAD(P)H vs. NRH
- Substrate specificity: Overlapping but not identical
- Expression patterns: Different tissue distributions
- Compensation: May partially compensate for each other
- Enzyme activity: Reflects cellular redox status
- Disease correlations: Altered in neurodegeneration
- Therapeutic monitoring: Response to antioxidants
- Activators: Compounds that enhance NQO2 activity
- Gene therapy: For boosting antioxidant defenses
- Combination approaches: With other antioxidants
- Spectrophotometric assays: Measure activity directly
- HPLC methods: For product analysis
- Fluorometric detection: Sensitive detection
- Knockout mice: NQO2-deficient mice
- Transgenic models: Overexpression studies
- Disease models: Neurodegeneration studies